Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Conditions

• Prostate Carcinoma

Eligibility Criteria

Sex

MALE

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Educational Intervention — OTHER
  Participate in educational session with health coach
• Genetic Testing — OTHER
  Undergo genetic testing
• Survey Administration — OTHER
  Complete surveys throughout course of study.
• ProGene Artificial Intelligence (AI) Platform — OTHER
  AI Platform to be used by health coach during sessions
• Interviews — OTHER
  Participant and provider interviews will be conducted by study staff.

Study Details

This clinical trial studies barriers to genetic testing in African American men with prostate cancer and whether tailored, culturally relevant genetic testing education provided by a community-based health coach is beneficial in improving knowledge, attitudes, and awareness of genetic testing. Information gained from this study, may help researchers better understand and learn more about how to increase access to germline genetic testing in underrepresented populations.

Key Dates

Start date

Jan 15, 2021

Status verified

Dec 2025

Primary completion

Mar 31, 2027

Completion

Mar 31, 2027

Study Design

Enrollment

72 participants (estimated)

Allocation

NON_RANDOMIZED

Intervention model

SEQUENTIAL

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• Active Comparator: CLOSED TO ENROLLMENT - Initial Pilot Cohort A (survey, genetic testing)
  Participants complete a survey about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences and use over 30 minutes at baseline and over 20 minutes at exit or follow up. Participants may also undergo genetic testing.
• Experimental: CLOSED TO ENROLLMENT -Initial Pilot Cohort B (educational session, survey, genetic testing)
  Participants engage in educational session with health coach over 60 minutes. Participants also complete a survey about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences and use over 30 minutes at baseline and over 20 minutes at exit or follow up. Participants may undergo genetic testing. Participant and provider interviews will be conducted at end of study.
• Experimental: Part 1 (educational session, survey, genetic testing)
  Participants engage in educational session lasting 15-30 minutes with health coach in-person or remotely who will be using a ProGene chatbot to augment the session over 15-30 minutes. Participants also complete surveys about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences. Participants may undergo genetic testing.
• Experimental: Part 2 Pilot (educational session, survey, genetic testing)
  Clinical participants engage in educational session lasting about 15-30 minutes with health coach in-person or remotely who will be using a ProGene chatbot to augment the session. Participants also complete surveys about knowledge of, attitudes towards, and awareness of genetic testing and technology preferences. Community and clinical participants may undergo genetic testing.

Primary Outcome Measure

Consent rate for germline testing (Initial Pilot Cohort and Part 2) [ Time Frame: At baseline (1 day) ]

Central Contacts

• UCSF Genitourinary Medical Oncology Recruitment
  877-827-3222
  [email protected]

Locations (3)

Find similar trials in San Francisco, CA

Related Studies

• Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
  Recruiting · University of Washington · Duarte, California
• Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
  Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
• 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
  EARLY_PHASE1 · Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
• Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
  Recruiting · City of Hope Medical Center · Duarte, California